<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00415428</url>
  </required_header>
  <id_info>
    <org_study_id>A2581154</org_study_id>
    <nct_id>NCT00415428</nct_id>
  </id_info>
  <brief_title>A Quality Ensuring Project With Focus On Patients With Cardiovascular Diseases As Well As Type 2 Diabetes.</brief_title>
  <official_title>Patient And Physician Alliance -Guideline Education Treatment Optimization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pfizer</source>
  <brief_summary>
    <textblock>
      The overall objective is to increase the adherence to national guidelines for patients with
      established CVD and/or Type 2 diabetes by means of repeated post-graduate educational
      meetings and regular evaluation of the optimisation initiatives, demonstrated by improvement
      of goal attainment in general practice.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">September 2008</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">2776</enrollment>
  <condition>Heart Diseases</condition>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>1.</arm_group_label>
    <description>Not Specified</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Patient adherence to national educational guidelines.</intervention_name>
    <arm_group_label>1.</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care clinic patients
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects had to meet all of the inclusion criteria to be eligible for enrollment into
             the study. The following subjects qualify for inclusion in the study:

          -  Subjects for whom measurement of total cholesterol, low density lipoprotein (LDL)
             cholesterol, blood pressure (BP) and glycosylated hemoglobin (HbA1c) was planned
             independently of this observational study and for whom baseline values were or became
             available.

          -  Subjects with known CVD diagnosed &gt; or = 6 months before inclusion

          -  Previous myocardial infarction

          -  Ischemic heart disease (stable and unstable angina pectoris)

          -  Ischemic apoplexy

          -  Peripheral arterial disease

          -  And/Or

          -  Subjects with T2D diagnosed &gt; or = 6 months before inclusion

          -  At least 50% of the subjects had to have CVD as the primary diagnosis. It was allowed
             for a secondary diagnosis to be &lt;6 months before inclusion.

        Exclusion Criteria:

          -  Subjects presenting with any of the following were not to be included in the study:

          -  Life expectancy of &lt; or = 2 years

          -  Unable/unwilling to understand/follow instructions

          -  Taking part in a clinical study involving an investigational drug

          -  Followed by a specialist for their CVD and/or T2D at the time of inclusion in the
             study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pfizer CT.gov Call Center</last_name>
    <role>Study Director</role>
    <affiliation>Pfizer</affiliation>
  </overall_official>
  <removed_countries>
    <country>Denmark</country>
  </removed_countries>
  <link>
    <url>https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A2581154&amp;StudyName=A%20Quality%20Ensuring%20Project%20With%20Focus%20On%20Patients%20With%20Cardiovascular%20Diseases%20As%20Well%20As%20Type%202%20Diabetes.</url>
    <description>To obtain contact information for a study center near you, click here.</description>
  </link>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2006</study_first_submitted>
  <study_first_submitted_qc>December 20, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2006</study_first_posted>
  <last_update_submitted>April 21, 2015</last_update_submitted>
  <last_update_submitted_qc>April 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

